Establish the uSI Values and End-user Training Material That Will be Used to Guide Oxytocin Dosing Actions

Inclusion Criteria: * Age 18 or greater * At least 37 weeks gestation * English reading and speaking * Female gender * Singleton fetus * Planned continuous external fetal monitoring: to include fetal heart rate and uterine contraction monitoring * May have clinical indications for internal monitoring (IUPC and/or FSE) that replaces external monitoring. * Induction or augmentation of labor with oxytocin (Pitocin) * Subjects undergoing artificial rupture of membranes (AROM) or who experienced spontaneous rupture of membranes (SROM), with a plan for oxytocin administration, will be included as a special category. * Subjects may undergo cervical ripening. * Patients must be able to review and sign informed consent to participate in the study. * Trial of labor after Cesarean section are eligible for participation * Women diagnosed with diabetes and/or pre-eclampsia with or without magnesium therapy are eligible for participation * Women with other complications of pregnancy are eligible for participation if the complication does not interfere with fetal monitoring, EMG monitoring or other recording of data. Exclusion Criteria: * Non-English reading and/or speaking * Twins, triplets and other multifetal gestations * Non-vertex presentation * Planned Cesarean delivery * Significant uterine anomalies such as didelphys or bicornuate uterus (women with small, clinically insignificant anomalies such as uterine fibroids are not excluded). * Participants cannot be participating in any …